Obesity and hidradenitis suppurativa: targeting meta-inflammation for therapeutic gain.

Dillon Mintoff, Rachel Agius, Farida Benhadou, Anupam Das, John W Frew, Nikolai P Pace

Journal: Clinical and experimental dermatology 2023;48(9):984-990

PMID: 37171791

Abstract

Hidradenitis suppurativa (HS) is a chronic, inflammatory condition of the pilosebaceous unit. The typical patient with HS is characterized as someone with obesity, who smokes and who has nodules, abscesses and/or draining tunnels predominantly distributed in intertriginous skin. It has been established that lifestyle and genetic factors are the main pathophysiological drivers of HS. In this critical review, we explore the interrelatedness of meta-inflammation, obesity and HS and discuss if and how this relationship may be manipulated for a therapeutic end.

© The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: [email protected].

Address: Department of Dermatology.; Department of Pathology, Faculty of Medicine and Surgery.; Diabetes and Endocrine Centre, Mater Dei Hospital, Msida, Malta.; Faculty of Medicine and Surgery.; Department of Dermatology, Hôpital Erasme, Universite Libre de Bruxelles, Bruxelles, Belgium.; Department of Dermatology, Venereology and Leprosy; KPC Medical College & Hospital, Kolkata, India.; Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.; Department of Dermatology, Liverpool Hospital, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia.; Centre for Molecular Medicine and Biobanking, University of Malta, Msida, Malta.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.